bpc-157 clinical trial human 2024 2025 If worked as well as the internet says it does… …we'd probably have high quality trials by now. Instead we have... Lots of rat studies. Lots of podcasts. Lots of An FDA Committee Just Voted

Keeping regular appointments can keep you healthy and energized

[11] [12] The measured endpoint in that combined-genotype work was folate deficiency rather than a B12-specific outcome, so the fair reading is that stacking one-carbon-cycle variants strains the shared methylation machinery, not that it selectively depletes B12

This ban lifting is baseless and will give the public a sense of legitimacy for a peptide with no clinical trial data to support safety or efficacy The pro-peptide stacked FDA advisory committee voted to lift the ban for BPC-157, as expected

What It Is: A longevity peptide that targets mitochondrial function the batteries of your cells